• Genfit announces the release of NASHnext

    1 month ago - By Healio

    Genfit, in association with Labcorp, announced the launch of a noninvasive nonalcoholic steatohepatitis test for at-risk patients, according to a press release.
    Using a novel, blood-based molecular biomarker test, NASHnext identifies NASH and significant fibrosis in patients with at least one metabolic risk factor. Researchers hope the widespread availability of this test will allow for clearer early diagnoses and aid in informed decision making to monitor or slow the progression of liver disease.
    “NASH is a widespread yet underdiagnosed liver disease with very serious consequences
    Read more ...